Filipa Lynce

41PUBLICATIONS
231CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer cell biologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Oct 19, 2026
Paxalisib with Trastuzumab for HER2-Positive Metastatic Breast Cancer with Active Brain Metastases: A Phase II Trial with Integrated Plasma and CSF ctDNA Analyses.

|Oct 07, 2026
PARP1-selective inhibitor DSB1559 demonstrates superior efficacy and antitumor immunity in triple-negative breast cancer.

|Aug 12, 2026
Real-world clinical outcomes of patients with early-stage TNBC and BRCAm who were treated with adjuvant capecitabine in the United States.

|May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies.

|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025.

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

Pageof 7

Frequent Collaborators

12 joint publications

Sara M Tolaney

7 joint publications

Ilana Schlam

5 joint publications

Claudine Isaacs

5 joint publications

Paolo Tarantino